drugset / Trial / NCT00585975

Efficacy and Safety of Bromfenac Ophthalmic Solution

NCT00585975

Phase 2 Completed 568 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a safety and efficacy study of bromfenac ophthalmic solution

Timeline

Start
2007-10
Primary completion
2008-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromfenac Other / unclassified 0.09 % Other
Subject Bromfenac Other / unclassified 0.18 % Other

Indications